QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.061671v1 309/3/1282    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matsubara, T. Articles by Yamazoe, Y. Search for Related Content PubMed PubMed Citation Articles by Matsubara, T. Articles by Yamazoe, Y.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Isolation and Characterization of a New Major Intestinal CYP3A Form, CYP3A62, in the Rat

Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan

Based on information of the nucleotide sequence obtained from rat genome clones, a new CYP3A (CYP3A62) cDNA was isolated from the cDNA library of a rat liver. The CYP3A62 cDNA was 1746 base pairs (bp) in length, which included 1491 bp of an open reading frame and 93 bp and 209 bp of the respective 5'- and 3'-noncoding regions. Amino acid sequence deduced from CYP3A62 cDNA shared the highest similarity with rat CYP3A9 (79.9%) among human and rat CYP3A forms previously reported. CYP3A62 mRNA and protein were consistently detected in small intestines as well as livers. CYP3A62 was a major form in small intestines of both sexes but was a female-predominant form in livers of adult rats. CYP3A62 in both tissues of male and female rats were clearly enhanced by the treatment with dexamethasone. These expression profiles resembled those of CYP3A9. Despite clear detection of CYP3A62, no detectable levels of CYP3A1 and CYP3A2 proteins, as well as those of mRNAs, were found in the intestinal tract. Therefore, CYP3A62 may play major roles together with CYP3A9 and CYP3A18 in endogenous or exogenous detoxification at the absorption site.

Address correspondence to: Kiyoshi Nagata, Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, 980-8578, Japan. E-mail: nagataki{at}mail.tains.tohoku.ac.jp

This article has been cited by other articles:

				T. Matsubara, K. Yoshinari, K. Aoyama, M. Sugawara, Y. Sekiya, K. Nagata, and Y. Yamazoe Role of Vitamin D Receptor in the Lithocholic Acid-Mediated CYP3A Induction in Vitro and in Vivo Drug Metab. Dispos., October 1, 2008; 36(10): 2058 - 2063. [Abstract] [Full Text] [PDF]

				D. Mitschke, A. Reichel, G. Fricker, and U. Moenning Characterization of Cytochrome P450 Protein Expression along the Entire Length of the Intestine of Male and Female Rats Drug Metab. Dispos., June 1, 2008; 36(6): 1039 - 1045. [Abstract] [Full Text] [PDF]

				M. Martignoni, G. Groothuis, and R. de Kanter COMPARISON OF MOUSE AND RAT CYTOCHROME P450-MEDIATED METABOLISM IN LIVER AND INTESTINE Drug Metab. Dispos., June 1, 2006; 34(6): 1047 - 1054. [Abstract] [Full Text] [PDF]

				T. K. H. Chang, J. Chen, and X. W. Teng DISTINCT ROLE OF BILOBALIDE AND GINKGOLIDE A IN THE MODULATION OF RAT CYP2B1 AND CYP3A23 GENE EXPRESSION BY GINKGO BILOBA EXTRACT IN CULTURED HEPATOCYTES Drug Metab. Dispos., February 1, 2006; 34(2): 234 - 242. [Abstract] [Full Text] [PDF]

				M. R. Uhing, D. W. A. Beno, V. A. Jiyamapa-Serna, Y. Chen, R. E. Galinsky, S. D. Hall, and R. E. Kimura THE EFFECT OF ANESTHESIA AND SURGERY ON CYP3A ACTIVITY IN RATS Drug Metab. Dispos., November 1, 2004; 32(11): 1325 - 1330. [Abstract] [Full Text] [PDF]